Fecal Microbiota Transplant National Registry

Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Feb 7, 2024

Keywords

ClinConnect Summary

The Fecal Microbiota Transplant National Registry is a clinical trial that aims to collect important information about the safety and effectiveness of fecal microbiota transplantation (FMT) and other related gut treatments. FMT involves transferring healthy bacteria from a donor’s stool to help improve gut health in patients who may be suffering from certain conditions. This study will gather data from medical records and phone calls to better understand how these treatments work over time. Please note that this study will not include newborns.

To participate, individuals must be able to provide informed consent and be planning to receive FMT or a similar gut treatment within 90 days of agreeing to join the study. Participants will also need access to the internet or a phone. Donors, who provide stool samples for FMT, must also meet similar consent criteria. It’s important to mention that people who are currently incarcerated cannot participate in this trial. Overall, participants can expect to contribute to valuable research that could help improve future treatments for gut health.

Gender

ALL

Eligibility criteria

• Recipient Inclusion Criteria :
• • Ability to give informed consent
• • Receiving FMT or other gut-related microbiota product within 90 days after providing consent
• • Access to internet and/or telephone
• Donor Inclusion Criteria:
• • Ability to give informed consent
• • Providing stool sample for FMT
• Exclusion Criteria:
• • Incarceration